.On the heels of an FDA rejection for its own primary rivalrous Novo Nordisk, Eli Lilly is actually ...
.Simply a couple of months after application the very first person in a period 2 test for recently d...
.Eli Lilly's look for being overweight targets has led it to the dark genome. The Big Pharma has cre...
.Collection Biosciences is carrying on up. The tissue therapy provider has added $325 million in amm...
.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has submitte...
.Aelis Farma's hopes of safeguarding a quick, favorable choice on a $100 million choice payment have...
.ProKidney has actually quit among a set of phase 3 tests for its tissue therapy for renal condition...
.Vaxcyte unveiled what experts named "magnificent" stage 1/2 data for its own 31-valent pneumococcal...
.Recursion has stumbled with an early examination of its own tech-enabled approach to drug discovery...
.Call it a case of good chemical make up: Acepodia, a biotech based upon Nobel Champion scientific r...